Additive effect of metabolic dysfunction-associated fatty liver disease on left ventricular function and global strain in type 2 diabetes mellitus patients: a 3.0 T cardiac magnetic resonance feature tracking study-Reference-Cited by-同舟云学术

Additive effect of metabolic dysfunction-associated fatty liver disease on left ventricular function and global strain in type 2 diabetes mellitus patients: a 3.0 T cardiac magnetic resonance feature tracking study

Published:2024-08-27 Issue:1 Volume:23 Page:
ISSN:1475-2840
Container-title:Cardiovascular Diabetology
language:en
Short-container-title:Cardiovasc Diabetol

Author:

Tang Xin,Shi Rui,Jiang Li,Yan Wei-Feng,Han Pei-Lun,Qian Wen-Lei,Yang Zhi-Gang,Li Yuan

Funder

Natural Science Foundation of Sichuan Province

the 1·3·5 project for disciplines of excellence of West China Hospital, Sichuan University

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1186/s12933-024-02410-z.pdf

Reference46 articles.

1. Galicia-Garcia U, Benito-Vicente A, Jebari S, Larrea-Sebal A, Siddiqi H, Uribe KB et al. Pathophysiology of type 2 diabetes Mellitus. Int J Mol Sci. 2020;21(17).

2. Khairnar R, Islam MA, Fleishman J, Kumar S. Shedding light on non-alcoholic fatty liver disease: Pathogenesis, molecular mechanisms, models, and emerging therapeutics. Life Sci. 2023;312:121185.

3. Wong ND, Sattar N. Cardiovascular risk in diabetes mellitus: epidemiology, assessment and prevention. Nat Rev Cardiol. 2023;20(10):685–95.

4. Badmus OO, Hinds TD Jr., Stec DE. Mechanisms linking metabolic-Associated fatty liver Disease (MAFLD) to Cardiovascular Disease. Curr Hypertens Rep. 2023;25(8):151–62.

5. Drożdż K, Nabrdalik K, Hajzler W, Kwiendacz H, Gumprecht J, Lip GYH. Metabolic-Associated fatty liver Disease (MAFLD), diabetes, and Cardiovascular Disease: associations with Fructose Metabolism and Gut Microbiota. Nutrients. 2021;14(1).